Redefining the Standard of Care in EGFR Mutated Lung Cancer

added blog Other

2026-04-29 07:16:32 -

The global pharmaceutical industry is witnessing a focused expansion in targeted inhibitors as the Tagrisso (osimertinib) Market was valued at USD 6.27 Billion in 2025 and is projected to grow to USD 9.20 Billion by 2033, with a compound annual growth rate (CAGR) of 4.9% from 2027 to 2033. This steady upward trajectory is a testament to the molecule’s ability to cross the blood-brain...

0 Comments 0 Shares 96 Views 0 Reviews